Patents by Inventor Mark A. Brudnak

Mark A. Brudnak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Microorganism enumeration methods
    Patent number: 9476084
    Abstract: This disclosure provides methods for enumeration of microorganisms within a freeze-dried powder suspected of containing Lactobacilli or Bifidobacteria.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: October 25, 2016
    Assignee: MAK WOOD, INC.
    Inventors: Mark A. Brudnak, Eric J. Baer
  • MICROORGANISM ENUMERATION METHODS
    Publication number: 20150291994
    Abstract: This disclosure provides methods for enumeration of microorganisms within a freeze-dried powder suspected of containing Lactobacilli or Bifidobacteria.
    Type: Application
    Filed: April 10, 2015
    Publication date: October 15, 2015
    Inventors: Mark A. Brudnak, Eric J. Baer
  • PROBIOTIC DOSAGE UNITS
    Publication number: 20150238549
    Abstract: A dosage unit including a probiotic component, a pH buffering agent, and a tonicity buffering agent. A dosage unit including a probiotic component, a polymeric matrix component, and a tonicity buffering agent, wherein the tonicity buffering agent is present in an amount and configuration suitable to provide a localized isotonic medium upon addition of the dosage unit to 50 mL of 0.1 N HCl (aq).
    Type: Application
    Filed: February 27, 2015
    Publication date: August 27, 2015
    Inventors: Mark A. Brudnak, Eric J. Baer
  • Composition and method for increasing exorphin catabolism to treat autism
    Patent number: 6783757
    Abstract: A composition for use in treating autism spectrum disorders. The composition preferably includes a genomeceutical type compound that increases the user's expression of DPPIV or like substances. The genomeceutical compound may include a sugar (such as a milk sugar), glucans, galactose and/or related material. The composition may also include one or more of a protease, peptidase or phytase. The inclusion of phospholipids, disaccharides, lipases and/or related substances in a composition for treating autism spectrum disorders and the function they provide is also disclosed.
    Type: Grant
    Filed: June 1, 2001
    Date of Patent: August 31, 2004
    Assignee: Kirkman Group, Inc.
    Inventor: Mark A. Brudnak
  • Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions
    Publication number: 20040005304
    Abstract: The present invention provides therapeutic compositions and methods for treating to neurological disorders and associated gastrointestinal conditions using enhancer molecules. These enhancer molecules comprise therapeutically effective amounts of metals, amino acids, polypeptides, saccharides, probiotics, and combinations thereof to enhance expression of genes, and/or enzymatic activity of gastrointestinal proteins.
    Type: Application
    Filed: July 8, 2002
    Publication date: January 8, 2004
    Applicant: MAK Wood, Inc.
    Inventor: Mark A. Brudnak
  • Genomeceutical and/or enzymatic composition and method for treating autism
    Publication number: 20020041871
    Abstract: A composition for use in treating autism spectrum disorders. The composition preferably includes a genomeceutical type compound that increases the user's expression of DPPIV or like substances. The genomeceutical compound may include a sugar (such as a milk sugar), glucans, galactose and/or related material. The composition may also include one or more of a protease, peptidase or phytase. The inclusion of phospholipids, disaccharides, lipases and/or related substances in a composition for treating autism spectrum disorders and the function they provide is also disclosed.
    Type: Application
    Filed: June 1, 2001
    Publication date: April 11, 2002
    Inventor: Mark A. Brudnak